In September 2025, the Therapeutic Goods Administration (TGA) issued a public safety alert after TGA laboratory testing revealed significant dose inconsistencies in unapproved melatonin products bought from overseas websites. Some products contained up to 400% more melatonin, while others contained less than stated or none.